Economic Analysis of Fluconazole versus Amphotericin B for the Treatment of Candidemia in Non-Neutropenic Patients

This publication has 15 references indexed in Scilit:

• An open study on the safety and efficacy of fluconazole in the treatment of disseminated Candida infections in patients treated for hematological malignancy
  Annals of Hematology, 1995
• A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia
  New England Journal of Medicine, 1994
• Pharmacokinetics and bioavailability of fluconazole in patients with AIDS
  Antimicrobial Agents and Chemotherapy, 1993
• Secular trends in nosocomial primary bloodstream infections in the United States, 1980–1989
  The American Journal of Medicine, 1991
• Candida Species: Emerging Hospital Bloodstream Pathogens
  Infection Control & Hospital Epidemiology, 1991
• Fluconazole
  Drugs, 1990
• Explaining Variability of Cost Using a Severity-of-lllness Measure for ICU Patients
  Medical Care, 1990
• Hospital-acquired candidemia. The attributable mortality and excess length of stay
  Archives of internal medicine (1960), 1988
• Identification and assessment of prognostic factors.
  1988
• Prognosis, Survival, and the Expenditure of Hospital Resources for Patients in an Intensive-Care Unit
  New England Journal of Medicine, 1981